eISSN: 2500-7106 / ISSN: 0123-2576
Register
Login
Medicinay Laboratorio
2025, Volume: 29, Issue:3-4 : 57-66 doi: 10.36384/01232576.725
Research Article
Total Hip Arthroplasty: Indications and Postoperative Functional Assessment
1
Dept. of Orthopaedics, All India Institute of Medical Sciences
Received
Sept. 12, 2025
Revised
Sept. 26, 2025
Accepted
Oct. 11, 2025
Published
Oct. 29, 2025
Abstract
Abstract Introduction: Total Hip Arthroplasty (THA) is one of the most successful orthopaedic surgical interventions, providing effective pain relief and restoration of function in patients with advanced hip pathology. Despite widespread use, comprehensive data on indications and postoperative functional outcomes from Indian tertiary centres remain limited.Material and Methods: This prospective observational study enrolled 80 patients who underwent THA at a tertiary orthopaedic centre over 24 months (January 2022–December 2023). Functional outcomes were assessed using the Harris Hip Score (HHS), Visual Analogue Scale (VAS), and WOMAC index preoperatively and at 3, 6, and 12 months postoperatively.Result: Mean age was 62.4 ± 10.2 years with male predominance (55%). Primary osteoarthritis was the most common indication (47.5%). Mean HHS improved significantly from 38.3 ± 7.4 preoperatively to 86.9 ± 6.3 at 12 months (p<0.001). VAS pain scores decreased from 7.8 ± 1.2 to 1.3 ± 0.9. Overall complication rate was 20%, with DVT being most common (5%). Excellent or good outcomes (HHS ≥80) were achieved in 82.5% of patients at 12 months.Conclusion: THA provides substantial and sustained improvement in pain relief and functional outcomes at 12 months. Primary osteoarthritis remains the dominant indication. Careful patient selection, standardised surgical technique, and structured rehabilitation are key determinants of success.
Keywords
License
Copyright (c) Medicinay Laboratorio
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Medicinay Laboratorio open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Lupus eritematoso sistémico
211-223
PDF
Impact of Severe Pre-eclampsia and Eclampsia on Fetomaternal Outcomes: A retrospective study
14-17
PDF
The role of the microbiology laboratory in clinical practice
295-296
PDF
Balance of the last three years: Adaptation and evolution towards a new stage
11-12
PDF
Medicinay Laboratorio journal thumbnail
Volume: 29, Issue:3-4
Citations
90 Views
376 Downloads
Share this article
Editora Médica Colombiana SA / Universidad de Antioquia
Certified Continuing Medical Education Program (PEMCC)
Email: submission@medicinaylaboratorio.com
Carrera 43C #5-33 Medellín, Colombia 050022
DOI: https://doi.org/10.36384/issn.0123-2576
Open Access Publication
Magazone managed by Biteca